你当前的位置: 首页 > 韩国专家库 > 药学

药学(171)

姓名:徐**

性别:男

国籍:韩国

联系电话:0631-5651499

E-Mail:xinhanrc@163.com

教育经历

首尔大学药学学士
首尔大学药学药学硕士
首尔大学药学药学博士
 

研究方向

主要成果

论文:国内外学术期刊发表论文60余篇
-“SG-SP1 Suppresses Mast Cell-Mediated Allergic Inflammation via Inhibition of Fc epsilon RI Signaling” - [FRONTIERS IN IMMUNOLOGY]
-“Total Synthesis of Naturally Occurring 5,7,8-Trioxygenated Homoisoflavonoids” - [ACS Omega]
-“Asymmetric Synthesis of Sappanin-Type Homoisoflavonoids” - [Asian Journal of Organic Chemistry]
-“Honokiol ameliorates angiotensin II-induced hypertension and endothelial dysfunction by inhibiting HDAC6-mediated cystathionine γ-lyase degradation” - [Journal of Cellular and Molecular Medicine]
-“Setd1a promotes proliferation of castration-resistant prostate cancer cells via FOXM1 transcription” - [Cancers]
-“Allyl isothiocyanate protects acetaminophen-induced liver injury via nrf2 activation by decreasing spontaneous degradation in hepatocyte” - [Nutrients]
-“Radiolabeled single-domain antibody for tumor receptor imaging” - [大韩放射性医药品学会杂志]
-“A novel ferrochelatase inhibitor decreases murine laser-induced choroidal neovascularization” - [INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE]
-“Enantioselective synthesis and absolute configuration determination of hydroxywilfordic acid in sesquiterpene pyridine alkaloids” - [ORGANIC & BIOMOLECULAR CHEMISTRY]
 
著书:《药品合成学》《无机和放射性药品学》
 
专利:25项(一种用于治疗血管增生疾病的化合物、一种含有克罗曼衍生物及其有效成分的用于预防或治疗新生血管性眼病或癌症的药物组合、一种新研制的同种异黄酮化合物及其制备方法以及含有该有效成分的预防或治疗缺血性脑损伤及多发性硬化症的药学组成物等。)